Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **glutathione-dependent sulfide detoxification pathway** constitutes a cellular defense system wherein glutathione (GSH), a tripeptide, participates in the reduction and conjugation of sulfide and related sulfur compounds to less toxic forms. This pathway is central to maintaining redox homeostasis and facilitating the cellular export of detoxified products, and is primarily regulated by enzymes such as glutathione reductase and glutathione-S-transferases. Enhancement of this pathway via glutathione replenishment—whether by supplementation, precursor drugs, or diet—can support cellular tolerance to sulfide and protection against oxidative stress, thereby contributing to disease prevention and therapeutic intervention in conditions linked to toxin exposure and metabolic dysfunction[1][3][4][5][6][7].
Augmentation of cellular glutathione stores for reduction of reactive sulfide and other electrophiles Activation of glutathione-dependent enzymes for conjugation and removal of toxic molecules Support of glutathione regeneration via glutathione reductase
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione-dependent sulfide detoxification pathway (null).